Scalable production of cardiomyocytes derived from c-Myc free induced pluripotent stem cells

Tissue Engineering - Part A

Volumn 17, Issue 7-8, 2011, Pages 1027-1037

  Zwi Dantsis, Limor ^a   Mizrahi, Itzhak ^a   Arbel, Gil ^a   Gepstein, Amira ^a   Gepstein, Lior ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROPHYSIOLOGY; GENES; STEM CELLS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

BIOPROCESSES; CARDIAC TROPONIN; CARDIOMYOCYTES; CONNEXIN-43; EMBRYOID BODY; FUNCTIONAL PROPERTIES; GAP JUNCTIONS; GENE EXPRESSION PATTERNS; HEPTANOL; ISOPROTERENOL; MULTIELECTRODE ARRAYS; PLURIPOTENT; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; RESEARCH AREAS; SCALABLE PRODUCTION; STATIC CULTURE; STRUCTURAL GENE; UNCOUPLERS;

CELL CULTURE;

IPS; MURINAE;

MYC PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; FLOW CYTOMETRY; GENETICS; HEART MUSCLE CELL; METABOLISM; MOUSE; PHYSIOLOGY; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; FLOW CYTOMETRY; INDUCED PLURIPOTENT STEM CELLS; MICE; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79952947143     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0235     Document Type: Article

References (31)

1. Laflamme, M.A., and Murry, C.E. Regenerating the heart. Nat Biotechnol 23, 845, 2005.
2. Takahashi, K., and Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663, 2006.
3. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861, 2007.
4. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917, 2007.
5. Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L.S., et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507, 2008.
6. Narazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498, 2008.
7. Zhang, J., Wilson, G.F., Soerens, A.G., Koonce, C.H., Yu, J., Palecek, S.P., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104, e30, 2009.
8. Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.H., et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513, 2009.
9. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26, 101, 2008.
10. Mogi, A., Ichikawa, H., Matsumoto, C., Hieda, T., Tomotsune, D., Sakaki, S., et al. The method of mouse embryoid body establishment affects structure and developmental gene expression. Tissue Cell 41, 79, 2009.
11. Nie, Y., Bergendahl, V., Hei, D.J., Jones, J.M., and Palecek, S.P. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog 25, 20, 2009.
12. Igelmund, P., Fleischmann, B.K., Fischer, I.R., Soest, J., Gryshchenko, O., Bohm-Pinger, M.M., et al. Action potential propagation failures in long-term recordings from embryonic stem cell-derived cardiomyocytes in tissue culture. Pflugers Arch 437, 669, 1999.
13. Kehat, I., Gepstein, A., Spira, A., Itskovitz-Eldor, J., and Gepstein, L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 91, 659, 2002.
14. Dang, S.M., Kyba, M., Perlingeiro, R., Daley, G.Q., and Zandstra, P.W. Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems. Biotechnol Bioeng 78, 442, 2002.
15. Zandstra, P.W., Bauwens, C., Yin, T., Liu, Q., Schiller, H., Zweigerdt, R., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9, 767, 2003.
16. Yirme, G., Amit, M., Laevsky, I., Osenberg, S., and Itskovitz-Eldor, J. Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev 17, 1227, 2008.
17. Lee, G., and Studer, L. Induced pluripotent stem cell technology for the study of human disease. Nat Methods 7, 25, 2010.
18. Ebert, A.D., and Svendsen, C.N. Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov 9, 367, 2010.
19. Kiskinis, E., and Eggan, K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120, 51, 2010.
20. Maltsev, V.A., Wobus, A.M., Rohwedel, J., Bader, M., and Hescheler, J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiacspecific genes and ionic currents. Circ Res 75, 233, 1994.
21. Schroeder, M., Niebruegge, S., Werner, A., Willbold, E., Burg, M., Ruediger, M., et al. Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng 92, 920, 2005.
22. Niebruegge, S., Nehring, A., Bar, H., Schroeder, M., Zweigerdt, R., and Lehmann, J. Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng Part A 14, 1591, 2008.
23. Wernig, M., Meissner, A., Cassady, J.P., and Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fi-broblasts. Cell Stem Cell 2, 10, 2008.
24. Jackson, T., Allard, M.F., Sreenan, C.M., Doss, L.K., Bishop, S.P., and Swain, J.L. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 10, 3709, 1990.
25. Izumo, S., Nadal-Ginard, B., and Mahdavi, V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85, 339, 1988.
26. Martinez-Fernandez, A., Nelson, T.J., Yamada, S., Reyes, S., Alekseev, A.E., Perez-Terzic, C., et al. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res 105, 648, 2009.
27. Illi, B., Scopece, A., Nanni, S., Farsetti, A., Morgante, L., Biglioli, P., et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res 96, 501, 2005.
28. Schmelter, M., Ateghang, B., Helmig, S., Wartenberg, M., and Sauer, H. Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation. FASEB J 20, 1182, 2006.
29. Wobus, A.M., Wallukat, G., and Hescheler, J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2\+ channel blockers. Differentiation 48, 173, 1991.
30. Takahashi, T., Lord, B., Schulze, P.C., Fryer, R.M., Sarang, S.S., Gullans, S.R., et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107, 1912, 2003.
31. Cameron, C.M., Hu, W.S., and Kaufman, D.S. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng 94, 938, 2006.